HRP970201B1 - Compositions for treating fungal infections - Google Patents

Compositions for treating fungal infections

Info

Publication number
HRP970201B1
HRP970201B1 HR970201A HRP970201A HRP970201B1 HR P970201 B1 HRP970201 B1 HR P970201B1 HR 970201 A HR970201 A HR 970201A HR P970201 A HRP970201 A HR P970201A HR P970201 B1 HRP970201 B1 HR P970201B1
Authority
HR
Croatia
Prior art keywords
compositions
fungal infections
treating fungal
treating
infections
Prior art date
Application number
HR970201A
Other languages
English (en)
Inventor
Maneesh J Nerurkar
William A Hunke
Michael J Kaufman
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26309400&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP970201(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9611006.9A external-priority patent/GB9611006D0/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of HRP970201A2 publication Critical patent/HRP970201A2/hr
Publication of HRP970201B1 publication Critical patent/HRP970201B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HR970201A 1996-04-19 1997-04-11 Compositions for treating fungal infections HRP970201B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1563896P 1996-04-19 1996-04-19
GBGB9611006.9A GB9611006D0 (en) 1996-05-24 1996-05-24 Antifungal compositions

Publications (2)

Publication Number Publication Date
HRP970201A2 HRP970201A2 (en) 1998-08-31
HRP970201B1 true HRP970201B1 (en) 2002-06-30

Family

ID=26309400

Family Applications (1)

Application Number Title Priority Date Filing Date
HR970201A HRP970201B1 (en) 1996-04-19 1997-04-11 Compositions for treating fungal infections

Country Status (36)

Country Link
EP (1) EP0904098B1 (hu)
JP (1) JP3258672B2 (hu)
CN (1) CN1132624C (hu)
AR (1) AR006598A1 (hu)
AT (1) ATE241999T1 (hu)
AU (1) AU706250B2 (hu)
BG (1) BG64272B1 (hu)
BR (2) BR9708706B8 (hu)
CA (1) CA2251928C (hu)
CO (1) CO4940486A1 (hu)
CY (1) CY2374B1 (hu)
CZ (1) CZ289361B6 (hu)
DE (1) DE69722615T2 (hu)
DK (1) DK0904098T3 (hu)
DZ (1) DZ2205A1 (hu)
EA (1) EA001386B1 (hu)
EE (1) EE04265B1 (hu)
ES (1) ES2198569T3 (hu)
HK (1) HK1020873A1 (hu)
HR (1) HRP970201B1 (hu)
HU (1) HU228296B1 (hu)
ID (1) ID16643A (hu)
IL (1) IL126479A (hu)
IS (1) IS2159B (hu)
MY (1) MY126305A (hu)
NO (1) NO321954B1 (hu)
NZ (1) NZ332156A (hu)
PE (1) PE63998A1 (hu)
PL (1) PL187294B1 (hu)
PT (1) PT904098E (hu)
RS (1) RS49566B (hu)
SA (1) SA97180104B1 (hu)
SK (1) SK281969B6 (hu)
TR (1) TR199802102T2 (hu)
UA (1) UA55409C2 (hu)
WO (1) WO1997039763A1 (hu)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1582204T3 (da) * 1999-03-03 2013-11-04 Lilly Co Eli Echinocandin-farmaceutiske formuleringer, der indeholder miceldannende overfladeaktive stoffer
TWI233805B (en) 1999-07-01 2005-06-11 Fujisawa Pharmaceutical Co Stabilized pharmaceutical composition in lyophilized form as antifungal agent
CN101516387B (zh) * 2006-07-26 2014-06-04 桑多斯股份公司 卡泊芬净制剂
ES2401299T5 (es) * 2006-07-26 2016-04-06 Sandoz Ag Formulaciones de caspofungina
US20100137197A1 (en) 2007-06-26 2010-06-03 Sachin Mittal Lyophilized anti-fungal composition
US8048853B2 (en) 2008-06-13 2011-11-01 Xellia Pharmaceuticals Aps Process for preparing pharmaceutical compound and intermediates thereof
EP2240507A2 (en) * 2008-06-25 2010-10-20 TEVA Gyógyszergyár Zártkörüen Müködö Részvénytársaság Processes for preparing high purity aza cyclohexapeptides
WO2010108637A1 (en) * 2009-03-27 2010-09-30 Axellia Pharmaceuticals Aps Crystalline compound
CN102219832B (zh) * 2010-04-15 2013-08-21 上海天伟生物制药有限公司 一种氮杂环六肽或其盐的纯化方法
CN102367267B (zh) * 2010-11-10 2013-09-04 上海天伟生物制药有限公司 一种卡泊芬净的制备方法
CN102367268B (zh) * 2010-11-10 2013-11-06 上海天伟生物制药有限公司 一种卡泊芬净类似物及其用途
CN102367269B (zh) * 2010-11-10 2013-11-06 上海天伟生物制药有限公司 一种卡泊芬净类似物及其制备方法和用途
CN102488888B (zh) * 2011-01-31 2014-07-30 上海天伟生物制药有限公司 一种含有棘白菌素类抗真菌剂的药用组合物及其制备方法和用途
CN102488887B (zh) * 2011-01-31 2014-06-18 上海天伟生物制药有限公司 一种含有棘白菌素类抗真菌剂卡泊芬净的药用组合物及其制备方法和用途
CN102614493B (zh) * 2011-01-31 2013-12-11 上海天伟生物制药有限公司 一种含有棘白菌素类抗真菌剂卡泊芬净的液体药用组合物
CN102166186A (zh) * 2011-04-18 2011-08-31 深圳市健元医药科技有限公司 一种更加稳定的氮杂环己肽类制剂
CN103315969B (zh) * 2011-09-26 2016-05-18 上海天伟生物制药有限公司 一种低杂质含量的卡泊芬净制剂及其制备方法和用途
CN102488889B (zh) * 2011-09-26 2014-01-22 上海天伟生物制药有限公司 一种低杂质含量的卡泊芬净制剂及其制备方法和用途
CN103212059A (zh) * 2012-01-18 2013-07-24 江苏恒瑞医药股份有限公司 含有抗真菌药物和乳酸盐缓冲液的组合物
RS64862B1 (sr) * 2012-03-19 2023-12-29 Cidara Therapeutics Inc Dozni režimi za jedinjenja klase ehinokandina
EP2992003B1 (en) 2013-05-02 2017-01-25 DSM Sinochem Pharmaceuticals Netherlands B.V. Method for isolating caspofungin
EP3058958B1 (en) 2015-02-23 2018-09-19 Selectchemie AG Anidulafungin composition
US11712459B2 (en) 2016-03-16 2023-08-01 Cidara Therapeutics, Inc. Dosing regimens for treatment of fungal infections
WO2019014333A1 (en) 2017-07-12 2019-01-17 Cidara Therapeutics, Inc. COMPOSITIONS AND METHODS FOR THE TREATMENT OF FUNGAL INFECTIONS
CN109721641B (zh) * 2017-10-31 2021-08-03 鲁南制药集团股份有限公司 一种卡泊芬净的合成方法
CN113801202A (zh) * 2020-06-15 2021-12-17 杭州中美华东制药有限公司 一种醋酸卡泊芬净杂质g的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1234383A (en) * 1982-03-17 1983-09-22 Inter-Yeda Ltd. Interferon stabilised with polyvinyl-pyrrolidone
JPH03504605A (ja) * 1988-05-27 1991-10-09 セントカー・インコーポレーテツド 抗体産生物の凍結乾燥した配合物
US5939384A (en) * 1991-10-01 1999-08-17 Merck & Co., Inc. Cyclohexapeptidyl propanolamine compounds
DE4305225A1 (de) * 1993-02-19 1994-08-25 Asta Medica Ag Neues Herstellverfahren für Cetrorelix Lyophilisat
US5378804A (en) * 1993-03-16 1995-01-03 Merck & Co., Inc. Aza cyclohexapeptide compounds
IL109350A (en) * 1993-05-12 2001-01-28 Genentech Inc Stable liquid preparations of gamma interferon

Also Published As

Publication number Publication date
NZ332156A (en) 2000-04-28
EA001386B1 (ru) 2001-02-26
IS4858A (is) 1998-10-02
PL187294B1 (pl) 2004-06-30
HRP970201A2 (en) 1998-08-31
NO321954B1 (no) 2006-07-31
BR9708706B1 (pt) 2013-08-06
JP3258672B2 (ja) 2002-02-18
HK1020873A1 (en) 2000-05-26
CA2251928A1 (en) 1997-10-30
TR199802102T2 (xx) 1999-01-18
DE69722615T2 (de) 2004-04-29
EA199800938A1 (ru) 1999-04-29
ATE241999T1 (de) 2003-06-15
PT904098E (pt) 2003-09-30
SK144898A3 (en) 1999-05-07
SK281969B6 (sk) 2001-09-11
AU706250B2 (en) 1999-06-10
EP0904098A1 (en) 1999-03-31
JPH11509555A (ja) 1999-08-24
CN1132624C (zh) 2003-12-31
AU2731197A (en) 1997-11-12
BG64272B1 (bg) 2004-08-31
HUP9901586A2 (hu) 1999-08-30
BR9708706B8 (pt) 2019-03-06
ES2198569T3 (es) 2004-02-01
CY2374B1 (en) 2004-06-04
EE04265B1 (et) 2004-04-15
ID16643A (id) 1997-10-23
CN1222082A (zh) 1999-07-07
AR006598A1 (es) 1999-09-08
NO984860L (no) 1998-12-18
IS2159B (is) 2006-11-15
UA55409C2 (uk) 2003-04-15
PE63998A1 (es) 1998-10-30
YU45098A (sh) 1999-07-28
BG102857A (en) 1999-09-30
WO1997039763A1 (en) 1997-10-30
CZ334798A3 (cs) 1999-06-16
IL126479A (en) 2006-08-01
HU228296B1 (en) 2013-03-28
BRPI9708706C8 (pt) 2021-01-05
PL329442A1 (en) 1999-03-29
EE9800345A (et) 1999-04-15
RS49566B (sr) 2007-04-10
NO984860D0 (no) 1998-10-16
MY126305A (en) 2006-09-29
CZ289361B6 (cs) 2002-01-16
IL126479A0 (en) 1999-08-17
DK0904098T3 (da) 2003-09-15
BR9708706A (pt) 1999-08-03
DE69722615D1 (de) 2003-07-10
DZ2205A1 (fr) 2002-12-03
CO4940486A1 (es) 2000-07-24
HUP9901586A3 (en) 2002-05-28
EP0904098B1 (en) 2003-06-04
SA97180104B1 (ar) 2006-02-08
CA2251928C (en) 2003-06-17

Similar Documents

Publication Publication Date Title
HRP970201B1 (en) Compositions for treating fungal infections
GB9600426D0 (en) Compositions
PL332118A1 (en) Remineralisable compositions
NZ330654A (en) Triazole derivatives useful for treating fungal conditions
GB9624874D0 (en) Composition
EP0676193A3 (en) Topically effective preparations.
HK1023371A1 (en) Compositions and methods for treating viral infections
PL323618A1 (en) Hide processing compositions
GB9612595D0 (en) Composition
IL126497A (en) Compositions for controlling harmful fungi
ZA974266B (en) Anti-vaginitis compositions for topical use
GB9619074D0 (en) Composition
GB9624881D0 (en) Coating compositions
GB9620504D0 (en) Compositions
GB9623562D0 (en) Sachet-packaged compositions
PL332546A1 (en) Pyrolydinyl- and pyrolynyl-ethylamine compounds as antigenes
GB9602266D0 (en) Composition
PL342098A1 (en) Pharmacological compositions for treating diskineses
GB9610966D0 (en) Composition
PL331889A1 (en) Composition for foghting against harmful fungi
PL330421A1 (en) Antiprespirant composition
EP0906085A4 (en) COMPOSITIONS
AU7108998A (en) Method for treating fungal infections
GB9600545D0 (en) Compositions
PL316034A1 (en) Auxiliary compositions

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
B1PR Patent granted
PNAN Change of the applicant name, address/residence

Owner name: MERCK SHARP & DOHME CORP., US

PNAN Change of the applicant name, address/residence

Owner name: SCHERING CORPORATION, US

Owner name: MERCK SHARP & DOHME CORP., US

ODRP Renewal fee for the maintenance of a patent

Payment date: 20160405

Year of fee payment: 20

PB20 Patent expired after termination of 20 years

Effective date: 19970411